An Unusual Case of Lorlatinib-Induced Pneumonitis: A Case Report

The discovery of tyrosine kinase oncogenic driver mutations, including anaplastic lymphoma kinase (ALK), has changed the face of non-small cell lung cancer (NSCLC) treatment. Whilst the development of tyrosine kinase inhibitors has improved survival, with their increasing use, it is important to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Philippa Kate, Boland, Helen E, Aherne, Noel J, Palmieri, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958573/
https://www.ncbi.nlm.nih.gov/pubmed/35431862
http://dx.doi.org/10.1159/000520158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958573/
https://www.ncbi.nlm.nih.gov/pubmed/35431862
http://dx.doi.org/10.1159/000520158

Ejemplares similares